🎉 M&A multiples are live!
Check it out!

Paragon 28 Valuation Multiples

Discover revenue and EBITDA valuation multiples for Paragon 28 and similar public comparables like Philips, Perspective Therapeutics, and SmartVest.

Paragon 28 Overview

About Paragon 28

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of revenue from the United States.


Founded

2010

HQ

United States of America
Employees

525

Website

paragon28.com

Financials

LTM Revenue $266M

LTM EBITDA -$5.7M

EV

$1.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Paragon 28 Financials

Paragon 28 has a last 12-month revenue of $266M and a last 12-month EBITDA of -$5.7M.

In the most recent fiscal year, Paragon 28 achieved revenue of $256M and an EBITDA of -$23.4M.

Paragon 28 expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Paragon 28 valuation multiples based on analyst estimates

Paragon 28 P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $216M $256M XXX XXX XXX
Gross Profit $149M $173M XXX XXX XXX
Gross Margin 69% 67% XXX XXX XXX
EBITDA -$26.9M -$23.4M XXX XXX XXX
EBITDA Margin -12% -9% XXX XXX XXX
Net Profit -$67.3M -$47.8M XXX XXX XXX
Net Margin -31% -19% XXX XXX XXX
Net Debt $4.4M $34.8M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Paragon 28 Stock Performance

As of April 15, 2025, Paragon 28's stock price is $13.

Paragon 28 has current market cap of $1.1B, and EV of $1.2B.

See Paragon 28 trading valuation data

Paragon 28 Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.2B $1.1B XXX XXX XXX XXX $-0.59

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Paragon 28 Valuation Multiples

As of April 15, 2025, Paragon 28 has market cap of $1.1B and EV of $1.2B.

Paragon 28's trades at 4.4x LTM EV/Revenue multiple, and -206.3x LTM EBITDA.

Analysts estimate Paragon 28's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Paragon 28 and 10K+ public comps

Paragon 28 Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.2B XXX XXX XXX
EV/Revenue 4.6x XXX XXX XXX
EV/EBITDA -49.8x XXX XXX XXX
P/E -20.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -26.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Paragon 28 Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Paragon 28 Valuation Multiples

Paragon 28's NTM/LTM revenue growth is 14%

Paragon 28's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, Paragon 28's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Paragon 28's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Paragon 28 and other 10K+ public comps

Paragon 28 Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 18% XXX XXX XXX XXX
EBITDA Margin -9% XXX XXX XXX XXX
EBITDA Growth -13% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 5% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 11% XXX XXX XXX XXX
Opex to Revenue 91% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Paragon 28 Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Paragon 28 M&A and Investment Activity

Paragon 28 acquired  XXX companies to date.

Last acquisition by Paragon 28 was  XXXXXXXX, XXXXX XXXXX XXXXXX . Paragon 28 acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Paragon 28

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Paragon 28

When was Paragon 28 founded? Paragon 28 was founded in 2010.
Where is Paragon 28 headquartered? Paragon 28 is headquartered in United States of America.
How many employees does Paragon 28 have? As of today, Paragon 28 has 525 employees.
Who is the CEO of Paragon 28? Paragon 28's CEO is Mr. Albert DaCosta.
Is Paragon 28 publicy listed? Yes, Paragon 28 is a public company listed on NYS.
What is the stock symbol of Paragon 28? Paragon 28 trades under FNA ticker.
When did Paragon 28 go public? Paragon 28 went public in 2021.
Who are competitors of Paragon 28? Similar companies to Paragon 28 include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Paragon 28? Paragon 28's current market cap is $1.1B
What is the current revenue of Paragon 28? Paragon 28's last 12-month revenue is $266M.
What is the current EBITDA of Paragon 28? Paragon 28's last 12-month EBITDA is -$5.7M.
What is the current EV/Revenue multiple of Paragon 28? Current revenue multiple of Paragon 28 is 4.4x.
What is the current EV/EBITDA multiple of Paragon 28? Current EBITDA multiple of Paragon 28 is -206.3x.
What is the current revenue growth of Paragon 28? Paragon 28 revenue growth between 2023 and 2024 was 18%.
Is Paragon 28 profitable? Yes, Paragon 28 is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.